Firebrick Pharma (ASX:FRE) raised around AU$800,000 via a share purchase plan at AU$0.055 apiece, according to a Thursday filing with the Australian bourse.
The pharmaceutical firm raised AU$635,600 following the completion of its share purchase plan comprising the issue of roughly 11.6 million fully paid ordinary shares.
Further, the company received commitments or applications for an additional AU$158,700 worth of shares. Settlement is expected to occur by Oct. 15.
Proceeds will be used to fund Firebrick Pharma's marketing initiatives for Nasodine nasal spray in Singapore and the US, the filing stated.
Firebrick Pharma's shares were up more than 7% in recent trade.
Price (AUD): $0.06, Change: $+0.0040, Percent Change: +7.27%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。